Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
NCT00047515
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Open-Angle Glaucoma
Ocular Hypertension
Interventions
DRUG:
Alcon Investigational Agent
Sponsor
Alcon Research